Physician

Roderick Henry Salach, D.O.

According to 2025 Medicare claims, Roderick Salach, D.O. (NPI: 1174627228) practices rheumatology in the Palm Bay-Melbourne-Titusville, FL market, with the plurality of this provider's patient population coming from Brevard, FL. This provider's primary affiliated billing organization is AMERICAN ARTHRITIS & RHEUMATOLOGY ASSOCIATES LLC (NPI: 1598205072; TIN: 831053374) and primary practice location at 32952-3616. Salach is affiliated with the Collaborative ACO 30, LLC (ACO ID: A5483) and Essentia Health ACO, Inc. (ACO ID: A5617), participating under the MSSP model.

Salach's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 617 traditional Medicare patients, billed 273,459 HCPCS/CPT codes, and received $2,507,635 in Medicare payments. The top billing code was 99215 (Established patient office or other outpatient visit with high level of medical decision making, if using time, 40 minutes or more). Part D data shows 3,348 prescription claims across 471 beneficiaries totaling $3,978,071 in drug costs, led by Rinvoq (Upadacitinib). 2016 DME data shows 11 claims. Open Payments data shows 99 records totaling $1,489. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has moved from a lower plateau to a higher plateau, from $1,105,293 to $2,507,635. Similarly, Part D prescription costs have moved from a lower plateau to a higher plateau, from $1,287,635 to $3,978,071. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Part B Carrier Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: Tot_Mdcr_Pymt_Amt. Source: Medicare Physician & Other Practitioners by Provider.0$1.3M$2.7M2015 Medicare payment: $1,105,293 (USD; Tot_Mdcr_Pymt_Amt)2016 Medicare payment: $1,266,306 (USD; Tot_Mdcr_Pymt_Amt)2017 Medicare payment: $1,279,964 (USD; Tot_Mdcr_Pymt_Amt)2018 Medicare payment: $1,397,465 (USD; Tot_Mdcr_Pymt_Amt)2019 Medicare payment: $1,787,263 (USD; Tot_Mdcr_Pymt_Amt)2020 Medicare payment: $2,308,736 (USD; Tot_Mdcr_Pymt_Amt)2021 Medicare payment: $2,668,181 (USD; Tot_Mdcr_Pymt_Amt)2022 Medicare payment: $2,613,819 (USD; Tot_Mdcr_Pymt_Amt)2023 Medicare payment: $2,137,000 (USD; Tot_Mdcr_Pymt_Amt)2024 Medicare payment: $2,507,635 (USD; Tot_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClm LinesPayment
2015983105,936$1,105,293
2016975104,442$1,266,306
2017931106,383$1,279,964
2018924110,005$1,397,465
2019918137,834$1,787,263
2020723197,696$2,308,736
2021736253,334$2,668,181
2022689195,484$2,613,819
2023618159,992$2,137,000
2024617273,459$2,507,635

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Part D Events Trend. X-axis: year 2015-2024. Y-axis: Drug cost, unit: USD. Field: Tot_Drug_Cst. Source: Medicare Part D Prescribers by Provider.0$2.0M$4.0M2015 Drug cost: $1,287,635 (USD; Tot_Drug_Cst)2016 Drug cost: $1,670,334 (USD; Tot_Drug_Cst)2017 Drug cost: $2,285,416 (USD; Tot_Drug_Cst)2018 Drug cost: $2,602,114 (USD; Tot_Drug_Cst)2019 Drug cost: $2,802,517 (USD; Tot_Drug_Cst)2020 Drug cost: $2,873,814 (USD; Tot_Drug_Cst)2021 Drug cost: $3,121,312 (USD; Tot_Drug_Cst)2022 Drug cost: $3,652,579 (USD; Tot_Drug_Cst)2023 Drug cost: $3,987,568 (USD; Tot_Drug_Cst)2024 Drug cost: $3,978,071 (USD; Tot_Drug_Cst)2015201620172018201920202021202220232024
YearPatientsClaimsDrug Cost
20156314,694$1,287,635
20166554,561$1,670,334
20176334,932$2,285,416
20186595,056$2,602,114
20196734,955$2,802,517
20205854,415$2,873,814
20215644,237$3,121,312
20225714,146$3,652,579
20235003,648$3,987,568
20244713,348$3,978,071

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

DME Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: DME_Suplr_Mdcr_Pymt_Amt. Source: Medicare DME, Devices & Supplies by Referring Provider.0$922$1.8K2015 Medicare payment: $1,844 (USD; DME_Suplr_Mdcr_Pymt_Amt)2016 Medicare payment: $70 (USD; DME_Suplr_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClaimsPayment
2015N/R30$1,844
2016N/R11$70
2017N/RN/RN/R
2018N/RN/RN/R
2019N/RN/RN/R
2020N/RN/RN/R
2021N/RN/RN/R
2022N/RN/RN/R
2023N/RN/RN/R
2024N/RN/RN/R

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

CodeDescriptionPatientsClm LinesTotal Payment
99215Established patient office or other outpatient visit with high level of medical decision making, if using time, 40 minutes or more128165$117
96413Administration of chemotherapy into vein, 1 hour or less105407$90
99214Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more366634$88
96401Administration of non-hormonal anti-neoplastic chemotherapy under skin or into muscle2011,108$53
G2211Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's260313$13

Top 5 Part D drugs in 2024

By total drug costs.

DrugGenericClaimsTotal Day SupplyTotal Drug Cost
RinvoqUpadacitinib1183,990$814,545
Humira(Cf) PenAdalimumab491,836$717,974
Enbrel SureclickEtanercept431,232$304,510
Xeljanz XrTofacitinib Citrate371,350$245,928
Orencia ClickjectAbatacept371,036$215,049

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

CategoryDefinitionRecordsTotal Reported AmountTop Related Entity
General PaymentsReported payment or transfer-of-value amount.99$1,489Amgen Inc.
Research PaymentsReported research-related payment or transfer-of-value amount.0$0N/R
Ownership / Investment InterestsReported value of ownership or investment interests.0$0N/R

FAQ

What Medicare data is available for Roderick Henry Salach, D.O.?

Tedicare shows public-source Medicare data for Roderick Henry Salach, D.O. (NPI 1174627228), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Roderick Henry Salach, D.O. have ACO affiliation data?

Roderick Henry Salach, D.O. is shown with ACO affiliation data for Collaborative ACO 30, LLC (MSSP, ACO ID A5483) and Essentia Health ACO, Inc. (MSSP, ACO ID A5617).

What billing organization is linked to Roderick Henry Salach, D.O.?

Roderick Henry Salach, D.O. is linked to AMERICAN ARTHRITIS & RHEUMATOLOGY ASSOCIATES LLC (billing NPI 1598205072) in the available physician profile data.

Does Roderick Henry Salach, D.O. have Open Payments data?

Roderick Henry Salach, D.O. has 99 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.